Skip to main content

Table 3 Treatment, complications and outcomes of patients with K. pneumoniae liver abscess with sepsis or without sepsis

From: Clinical features and development of Sepsis in Klebsiella pneumoniae infected liver abscess patients: a retrospective analysis of 135 cases

Characteristic

Total

n = 135

KPLA with sepsis

n = 37

KPLA without sepsis

n = 98

P value

Complications

 Sepsis shock

8 (5.9)

7 (18.9)

1 (1.0)

0.000a

 Acute Respiratory Distress Syndrome

4 (3.0)

4 (10.8)

0

0.005a

 Acute kidney injury

2 (1.5)

2 (5.4)

0

0.074 a

 Pleural effusion

11 (8.1)

4 (10.8)

7 (7.1)

0.493 a

 Spontaneous bacterial peritonitis

2 (1.5)

2 (5.4)

0

0.074 a

Metastatic infections

 Lung

11 (8.1)

9 (24.3)

2 (2.0)

0.000a

 Eye

4 (3.0)

4 (10.8)

0

0.005a

 CNS

1 (0.7)

1 (2.7)

0

0.274a

 Others

4 (3.4)

3 (8.1)

1 (1.0)

0.063a

Hospital length of stay, days

14.5 ± 9.0

20.7 ± 9.5

12.2 ± 7.7

0.000

ICU admission

14 (10.4)

11 (29.7)

3 (3.1)

0.000a

Readmission

8 (5.9)

2 (5.4)

6 (6.1)

1.000a

Treatment

   

0.696

 Antibiotics alone

7 (5.2)

1 (2.7)

6 (6.1)

 

 Antibiotics+Percutaneous drainage

122 (90.4)

34 (91.9)

88 (89.8)

 

 Antibiotics+Surgical drainage

6 (4.4)

2 (5.4)

4 (4.1)

 

Antibiotic drugs

 Beta-lactamase inhibitors

38 (28.1)

18 (48.6)

20 (20.4)

0.001

 The third generation of cephalosporin

59 (43.7)

18 (48.6)

41 (41.8)

0.477

 Fluoroquinolone

51 (37.8)

17 (45.9)

34 (34.7)

0.229

 Carbapenems

96 (71.1)

31 (83.8)

65 (66.3)

0.046

 Metronidazole

57 (42.2)

16 (43.2)

41 (41.8)

0.883

Clinical outcomes

   

0.074a

 Cured

133 (98.5)

35 (94.6)

98 (100)

 

 Died (Poor prognosis)

2 (1.5)

2 (5.4)

0